Osteomark

Osteomark®

Metabolism A proprietary urine test for measuring bone loss, quantifying cross-linked N-telopeptides–NTx, which are degradation products of bone resorption and are unique biochemical markers specific for the type I collagen–found in bone. See Hormone replacement therapy, N-telopeptides, Osteoporosis.
References in periodicals archive ?
A group of researchers compared the Pyrilinks-D test to other bone resorption tests like Osteomark and CrossLaps.
A urine test developed by OSTEOMARK can determine whether a woman's body is losing bone density.
sALP was determined by the Tandem-MP Ostase Immunoenzymetric Assay (Beckman Coulter) (10) and NTx by the Osteomark NTx Assay (Ostex International) (11).
Forward-looking statements in this release involve a number of risks and uncertainties including, but not limited to, product demand, pricing, market acceptance of the Osteomark tests, changing economic conditions, the actions of competitors, the effect of the Company's accounting policies, meeting regulatory requirements for the Company's new products and other risk factors detailed in the Company's SEC filings.
Forward looking statements in this release involve a number of risks and uncertainties including, but not limited to, product demand, pricing, market acceptance of the Osteomark tests, changing economic conditions, the actions of competitors, the effect of the Company's accounting policies, meeting regulatory requirements for the Company's new products and other risk factors detailed in the Company's SEC filings.
Thomas Bologna, Ostex' Chairman, President and Chief Executive Officer, stated, "The acquisition of the manufacturing and expanded use rights for the Osteomark Point-of-Care device represents a key strategic opportunity for our Company.
Our results for the first quarter were compounded by delayed shipments of the Osteomark NTx Urine kits in late March.
The Company's lead product, the Osteomark NTx test, now available in multiple test formats, incorporates breakthrough and patented technology for the management and prevention of osteoporosis.
The company's lead product, the Osteomark NTx urine test, incorporates breakthrough and patented technology in the area of bone resorption measurement.